Partnerships that get results: Global. Fluid. Connected. Join Us!

Loyola University Medical Center

Department of Medicine

Division of Hepatology

2160 S. First Ave
Mulcahy Center, Rm 1610

Maywood, IL 60153, USA


Phone: 708-216-4682

Fax: 708-216-6299

Sneak Peek to our Preprint in Lancet

January 29, 2020


To our knowledge, this is the first prospective clinical trial assessing the utility of a response guided therapy approach based on mathematical modeling to individualize treatment duration with DAAs in CHC. Model-based decisions led to treatment shortening in 38% of patients and to an overall time saving of 14% in treatment duration. Implementation of the model was safe and did not compromise treatment efficacy.


Implementation of an RGT approach for treatment of HCV on a larger scale could lead to a significant reduction in treatment cost. This may improve access to HCV care especially in resource limited settings and facilitate the goal of HCV elimination.


Read Full Publication Here!

Please reload

Recent Posts

Please reload


Please reload


Please reload